Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: A pragmatic randomized controlled trial

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 3, 2011, Pages 1586-1592

  Lois, Noemi ^a   Burr, Jennifer ^b   Norrie, John ^b,c   Vale, Luke ^b,d   Cook, Jonathan ^b   McDonald, Alison ^b   Boachie, Charles ^b   Ternent, Laura ^b,d   McPherson, Gladys ^b  

^a NHS GRAMPIAN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CAPSULOTOMY; CHOROID HEMORRHAGE; CONTRAST SENSITIVITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; INTERNAL LIMITING MEMBRANE PEELING; INTRAOCULAR PRESSURE ABNORMALITY; IRELAND; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; READING; REOPERATION; RETINA DETACHMENT; RETINA DETACHMENT SURGERY; RETINA HEMORRHAGE; RETINA MACULA HOLE; RETINA SURGERY; RETINA TEAR; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED KINGDOM; VISION; VISUAL ACUITY; VITRECTOMY;

AGED; CONTRAST SENSITIVITY; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EPIRETINAL MEMBRANE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUOROCARBONS; FOLLOW-UP STUDIES; HEALTH RESOURCES; HUMANS; MALE; PHACOEMULSIFICATION; QUALITY-ADJUSTED LIFE YEARS; RETINAL PERFORATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITRECTOMY; VITREORETINAL SURGERY;

EID: 79955930425     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6287     Document Type: Article

References (21)

1. Casuso LA, Scott IU, et al. Long-term follow-up of unoperated macular holes. Ophthalmology. 2001;108:1150-1155.
2. McCannel CA, Ensminger JL, Diehl NN, Hodge DN. Populationbased incidence of macular holes. Ophthalmology. 2009;116: 1366-1369.
3. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol. 1991;109:654-659.
4. Ah-Fat FG, Sharma MC, Majid MA, McGalliard JN, Wong D. Trends in vitreoretinal surgery at a tertiary referral centre: 1987 to 1996. Br J Ophthalmol. 1999;83:385-386.
5. Gass JD. Idiopathic senile macular hole: its early stages and pathogenesis. Arch Ophthalmol. 1988;106:629-639.
6. Kim JW, Freeman WR, Azen SP, el-Haig W, Klein DJ, Bailey IL. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes: Vitrectomy for Macular Hole Study Group. Am J Ophthalmol. 1996;121:605-614.
7. Freeman WR, Azen SP, Kim JW, el-Haig W, Mishell DR III, Bailey I. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes: results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol. 1997;115:11-21.
8. Eckardt C, Eckardt U, Groos S, Luciano L, Reale E. Removal of the internal limiting membrane in macular holes: clinical and morphological findings (in German). Ophthalmologe. 1997;94:545-551.
9. Abdelkader E, Lois N. Internal limiting membrane peeling in vitreoretinal surgery. Surv Ophthalmol. 2008;53:368-396.
10. Christensen UC, Kroyer K, Sander B, et al. Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. Br J Ophthalmol. 2009; 93:1005-1015.
11. Kwok AK, Lai TY, Wong VW. Idiopathic macular hole surgery in Chinese patients: a randomised study to compare indocyanine green-assisted internal limiting membrane peeling with no internal limiting membrane peeling. Hong Kong Med J. 2005;11:259-266.
12. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5):464-475.
13. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974;15:443-453.
14. Brooks HL Jr. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology. 2000;107:1939-1948.
15. Paques M, Chastang C, Mathis A, et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology. 1999;106:932-938.
16. British National Formulary 57. London: BMJ Group and RPS Publishing; 2009. Available at: http://bnf.org/bnf/index.htm. Accessed June 2009.
17. ISD Scotland. Edinburgh: Information Services Division, NHS National Services Scotland; 2009. Available at: http://www.isdscotland.org/isd/1.html. Accessed June 2009.
18. Curtis L. Unit Costs for Health and Social Care. University of Kent: Personal Social Services Research Unit; 2008. Available at: http://www.pssru.ac.uk/uc/uc2008contents.htm. Accessed June 2009.
19. Dolan P, Gudex C, Kind P, et al. A social tariff for Euroqol: results from a UK general population survey. Discussion Paper 138. Heslington, UK: University of York: Centre for Health Economics; 1995. Available from: URL: Available at: http://www.york.ac.uk/inst/che/pdf/DP138.pdf. Accessed June 2009.
20. Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, for the Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group. Clinical and cost-effectiveness of internal limiting membrane peeling for patients with idiopathic full thickness macular hole: protocol for a Randomised Controlled Trial. FILMS (Full-thickness macular hole and Internal Limiting Membrane peeling Study). Trials. 2008;3:61.
21. Terasaki H, Miyake Y, Nomura R, et al. Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci. 2001;42:229-234.